| All n=50 | Survivors n=37 | Non-survivors n=13 | p |
---|---|---|---|---|
Clincal data | ||||
Median age, y | 65 (54–74) | 60.5 (49.5–72.0) | 72.0 (69.0–76.0) | 0.033 |
Female sex, n (%) | 14 (28) | 12 (32) | 2 (15) | >0.1 |
Diabetes mellitus, n (%) | 6 (12) | 5 (14) | 1 (8) | >0.1 |
Hypertension, n (%) | 12 (24) | 11 (30) | 1 (8) | >0.1 |
Cardiac disease, n (%) | 12 (24) | 8 (22) | 4 (31) | >0.1 |
APACHE II score | 24 (19–29) | 24 (17–28) | 28 (21–34) | 0.060 |
SOFA score | 12 (9–14) | 10 (9–13) | 13 (13–14) | 0.007 |
HR, beats/min | 99 (85–115) | 99 (85–116) | 98 (83–107) | >0.1 |
MAP, mmHg | 76 (70–88) | 76 (70–90) | 76 (73–79) | >0.1 |
NE dose, μg/kg/min | 0.09 (0.05-0.14) | 0.08 (0.04-0.13) | 0.1 (0.09-0.18) | >0.1 |
CRRT, n (%) | 14 (28) | 11 (30) | 3 (23) | >0.1 |
Fluids, ml/kg/24h | 43 (22–84) | 38 (20–81) | 46 (28–77) | >0.1 |
Mechanical ventilation, n (%) | 45 (90) | 35 (95) | 10 (77) | >0.1 |
Peep, cmH2O | 8 (5–10) | 8 (5–10) | 10 (9–13) | 0.083 |
Biochemical data | Â | Â | Â | Â |
Creatinine, μmol/L | 156 (94–243) | 138 (86–221) | 182 (118–246) | >0.1 |
Lactate mmol/L | 2.2 (1.6-3.2) | 2.2 (1.6-3.2) | 2.6 (1.8-4.6) | >0.1 |
hsTNT, ng/L | 79.5 (23–182) | 77.5 (18.6-125.3) | 152 (80–501) | 0.014 |
BNP, pmol/L | 187 (98–375) | 157 (84–356) | 262 (183–440) | >0.1 |
Echocardiographic data | n=47 | n=34 | n=13 | Â |
LVEF, % | 49 (40:55) | 50 (40–50) | 45 (35–65) | >0.1 |
LVEF, %, mean (±SD) | 47 (±14.8) | 47 (±12.8) | 48 (±19.7) |  |
MAPSE, mm | 10 (8.0-12.6) | 11 (8.9-13) | 8 (7.5-11) | 0.028 |
MAPSE, mm, mean (±SD) | 10.3 (±2.8) | 10.9 (±2.9) | 8.7 (±2.5) |  |
TDIs cm/s | 8.9 (7.1-10.0) | 8.9 (7.2-9.9) | 7.5 (6.6-10) | >0.1 |
E/A | 1.2 (0.9-1.5) | 1.2 (0.9-1.5) | 1.3 (0.9-1.6) | >0.1 |
é, cm/s | 8.3 (7–10) | 8.4 (7.5-10.5) | 7.2 (6.3-8.6) | >0.1 |
é, cm/s, mean (±SD) | 8.7 (±2.2) | 8.9 (±2.0) | 8.0 (±2.6) |  |
E/é | 10.2 (8.5–12) | 10.0 (8.2–11.5) | 13.0 (9.6–15.2) | 0.055 |
E/é, mean (±SD) | 10.7 (±3.7) | 9.8 (±2.8) | 12.7 (±5.0) |  |